Urgent Product Withdrawal - OXBRYTA ® (voxelotor) - Maryland Sickle Cell Disease Association

Urgent Product Withdrawal – OXBRYTA ® (voxelotor)

Pfizer announces the withdrawal of OXBRYTA ® (voxelotor) for the treatment of sickle cell in all markets.

Maryland Sickle Cell Disease Association
8775 Centre Park Drive Suite 701
Columbia, Maryland 21045
410.465.4822

Sign up for our email list, or follow us on social media, to stay in-the-know about the Maryland Sickle Cell Disease Association

I am person diagnosed with sickle cell disease/trait I am a caregiver of a person diagnosed with sickle cell/ trait Other

Scroll to Top

Maryland Statewide Sickle Cell Picnic

Join Us on Saturday, September 19, 2026 for Our 8th Annual Family Day Picnic